Genomic Health   Report issue

For profit Phase 2 Phase 3
Founded: Redwood City CA United States (2000)
Status: Acquired by Exact Sciences (2019)

Organization Overview

First Clinical Trial
2018
NCT03447132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Genomic Health®, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6